Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy
Authors
Keywords
-
Journal
Targeted Oncology
Volume 16, Issue 3, Pages 325-337
Publisher
Springer Science and Business Media LLC
Online
2021-04-25
DOI
10.1007/s11523-021-00814-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cervical chordomas: multicenter case series and meta-analysis
- (2021) Oluwaseun O. Akinduro et al. JOURNAL OF NEURO-ONCOLOGY
- Apatinib in patients with advanced chordoma: a single-arm, single-centre, phase 2 study
- (2020) Chao Liu et al. LANCET ONCOLOGY
- Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review
- (2019) Tong Meng et al. Frontiers in Oncology
- Chordoma
- (2019) Anna Maria Frezza et al. CURRENT OPINION IN ONCOLOGY
- A Phase 1 Dose Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
- (2019) Margaret E Gatti-Mays et al. CLINICAL CANCER RESEARCH
- Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma
- (2018) Ryohei Otani et al. JOURNAL OF NEUROSURGERY
- Imatinib and Everolimus in Patients With Progressing Advanced Chordoma: A Phase 2 Clinical Study
- (2018) Silvia Stacchiotti et al. CANCER
- A Phase I Study of Nilotinib plus Radiation in High-Risk Chordoma
- (2018) Gregory M. Cote et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF)
- (2017) Loïc Lebellec et al. EUROPEAN JOURNAL OF CANCER
- Effects of primary and recurrent sacral chordoma on the motor and nociceptive function of hindlimbs in rats: an orthotopic spine model
- (2017) Rachel Sarabia-Estrada et al. JOURNAL OF NEUROSURGERY-SPINE
- CDK4 expression in chordoma: A potential therapeutic target
- (2017) Tang Liu et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury
- (2017) Paola Magnaghi et al. MOLECULAR CANCER THERAPEUTICS
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- Differences in Dural Penetration of Clival Chordomas Are Associated with Different Prognosis and Expression of Platelet-Derived Growth Factor Receptor-β
- (2017) Yixuan Zhai et al. World Neurosurgery
- Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis
- (2017) Ivan J. Lee et al. World Neurosurgery
- Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer
- (2017) Sagar R. Shah et al. Cell Reports
- Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor
- (2016) Scott M. Schuetze et al. CANCER
- Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
- (2016) V. M. Macaulay et al. CLINICAL CANCER RESEARCH
- SOX9 and the many facets of its regulation in the chondrocyte lineage
- (2016) Véronique Lefebvre et al. CONNECTIVE TISSUE RESEARCH
- Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers
- (2016) Wenzhe Song et al. CURRENT CANCER DRUG TARGETS
- Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer
- (2016) Duane H Hamilton et al. ENDOCRINE-RELATED CANCER
- Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors
- (2016) Arnault Tauziède-Espariat et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen
- (2016) Susanne Scheipl et al. JOURNAL OF PATHOLOGY
- Safety and Local Control of Radiation Therapy for Chordoma of the Spine and Sacrum
- (2016) Brenton Pennicooke et al. SPINE
- Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers
- (2016) Kwaku Appiah-Kubi et al. TUMOR BIOLOGY
- Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO)
- (2016) Loic Lebellec et al. Oncotarget
- Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling
- (2016) Carmen Oi-Ning Leung et al. Oncotarget
- Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas
- (2015) Markku Miettinen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)
- (2015) E. Bompas et al. ANNALS OF ONCOLOGY
- Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway
- (2015) Adrian von Witzleben et al. CANCER RESEARCH
- Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
- (2015) Yong Feng et al. Oncotarget
- Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
- (2015) C. R. Heery et al. Cancer Immunology Research
- Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma
- (2015) Kathleen M. Capaccione et al. Oncotarget
- The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival
- (2014) Yunping Hu et al. CARCINOGENESIS
- Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness
- (2014) Giuseppina Raspaglio et al. GENE
- PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
- (2014) Dimitrios Mathios et al. JOURNAL OF NEURO-ONCOLOGY
- Expression of PTEN and mTOR in sacral chordoma and association with poor prognosis
- (2014) Kangwu Chen et al. MEDICAL ONCOLOGY
- Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1
- (2014) Edwin Choy et al. PLoS One
- Phase II study on lapatinib in advanced EGFR-positive chordoma†
- (2013) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours
- (2013) A Adenis et al. BRITISH JOURNAL OF CANCER
- Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)
- (2013) T. Valentin et al. INVESTIGATIONAL NEW DRUGS
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- Epigenetic Regulation of SOX9 by the NF-κB Signaling Pathway in Pancreatic Cancer Stem Cells
- (2013) Lei Sun et al. STEM CELLS
- PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes
- (2012) Ipsita Pal et al. ACTA PHARMACOLOGICA SINICA
- Brachyury, a Driver of the Epithelial-Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer
- (2012) M. Roselli et al. CLINICAL CANCER RESEARCH
- Phase II Study of Imatinib in Advanced Chordoma
- (2012) Silvia Stacchiotti et al. JOURNAL OF CLINICAL ONCOLOGY
- A common single-nucleotide variant in T is strongly associated with chordoma
- (2012) Nischalan Pillay et al. NATURE GENETICS
- Role of Cancer Stem Cells in Spine Tumors
- (2012) Wesley Hsu et al. NEUROSURGERY
- An EGFR-ERK-SOX9 Signaling Cascade Links Urothelial Development and Regeneration to Cancer
- (2011) S. Ling et al. CANCER RESEARCH
- Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target
- (2011) Wesley Hsu et al. JOURNAL OF NEUROSURGERY
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma
- (2010) Kang-Wu Chen et al. JOURNAL OF NEURO-ONCOLOGY
- Response to imatinib plus sirolimus in advanced chordoma
- (2009) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
- (2009) N Presneau et al. BRITISH JOURNAL OF CANCER
- Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
- (2009) Suzanne George et al. JOURNAL OF CLINICAL ONCOLOGY
- T (brachyury) gene duplication confers major susceptibility to familial chordoma
- (2009) Xiaohong R Yang et al. NATURE GENETICS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More